Pseudoxanthoma elasticum: Significance of limited phenotypic expression in parents of affected offspring

https://doi.org/10.1067/mjd.2001.112401Get rights and content

Abstract

The inheritance pattern of pseudoxanthoma elasticum (PXE) is controversial. Inheritance patterns are confounded by delayed diagnosis and mild or limited phenotypic expression among certain family members. Because testing for the genetic mutation(s) responsible for PXE is not routine, genetic counseling must be done with caution. We describe 4 families in which one or more children were diagnosed with PXE. Detailed examination of the parents was carried out, including skin biopsy and ophthalmologic examination. In 3 of the 4 families, one parent had limited phenotypic expression, such as ocular findings without skin lesions or very mild skin lesions with no ocular findings. In the other family, one parent had very mild skin and ocular disease. All 4 affected parents had diagnostic skin biopsy findings. In none of the 4 families was the inheritance pattern clear-cut. Although the inheritence pattern of PXE has been debated, clinically significant stigmata of PXE, which are not always readily apparent, can occur in successive generations. Therefore all first-degree relatives of affected patients should receive a full dermatologic examination as well as a funduscopic examination. If even mild typical skin or eye findings are present, then skin biopsy should be performed. (J Am Acad Dermatol 2001;44:534-7.)

Section snippets

Case 1

A 15-year-old boy was diagnosed with PXE at age 14 years. He had characteristic skin lesions on the neck, first noted at age 7, peau d'orange change on funduscopic examination, and a biopsy specimen of lesional skin that revealed calcification and fragmentation of elastic fibers in the mid dermis.

The patient's family, including two brothers aged 5 and 19 years, his 39-year-old father, and 40-year-old mother were subsequently examined. No evidence of PXE was found in the father or two brothers.

Discussion

Hereditary disorders often have a prolonged time lapse between clinical onset and diagnosis. However, the delay in diagnosis of PXE is unusually long, averaging about 9 years.8 This makes early intervention difficult. The disease is often not diagnosed until the fourth or fifth decade of life because the clinical manifestations and complications have not become noticeable or severe enough to warrant medical attention. In addition, further delay occurs because few physicians have been adequately

Acknowledgements

We thank Wayne Fuchs, MD, and Lloyd Wilcox, MD, for their assistance in ophthalmologic evaluation of case 1; Sharon Terry, PXE International, Inc, for providing assistance with patient and family contacts; and Dianne Abuelo, MD, for helpful suggestions.

References (14)

There are more references available in the full text version of this article.

Cited by (53)

  • Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?

    2020, Bone
    Citation Excerpt :

    PXE causes calcification of elastic fibers in skin, retina, and arteries [3,32,33]. Some heterozygous defects of ABCC6 lead to limited manifestations of PXE (Forme Fruste, OMIM # 177850) [3,34–36] including vascular calcification. Homozygous or compound heterozygous missense mutations near Patient 1's heterozygous ABCC6 variant (e.g. Trp256Arg) have been reported in PXE.

  • Genetics of neurocutaneous disorders. basic principles of inheritance as they apply to neurocutaneous syndromes.

    2015, Handbook of Clinical Neurology
    Citation Excerpt :

    Carriers of one mutation are typically asymptomatic. It is possible that carriers of an ABCC6 mutation may have mild ocular and cutaneous findings, but this is currently under debate in the literature (Bacchelli et al., 1999; Sherer et al., 2001; Martin et al., 2008). Of note, an increased risk for PXE is seen in a few populations including the Afrikaners in South Africa, who display a founder effect, defined as reduced genetic variation in an isolated population descending from a small group of ancestors (Le Saux et al., 2002).

  • Hurwitz Clinical Pediatric Dermatology, Fouth Edition

    2011, Hurwitz Clinical Pediatric Dermatology, Fouth Edition
  • Disorders of elastic tissue

    2009, Weedon's Skin Pathology: Third Edition
View all citing articles on Scopus

Reprint requests: Daniel W. Sherer, MD, The Mount Sinai Medical Center, Department of Dermatology, 5 E 98th St, 6th Floor, Box 1048, New York, NY 10029-6574.

View full text